ArticleJCO precision oncology2022

Clinical Opportunities for Germline Pharmacogenetics and Management of Drug-Drug Interactions in Patients With Advanced Solid Cancers.

Tyler Shugg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.